|
|
|
|
|
|
| Global CRO Strengthens Staff Expertise through World-Class Professional Development to Deliver Exceptional Clinical Development Programs |
Raleigh, NC, Aug 24, 2012 - (ACN Newswire) - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced it has been accredited as an Authorized Provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs to ultimately enhance delivery of clinical development solutions of the highest quality for customers. As the world's only global CRO Authorized Provider, INC Research significantly enhances the quality of its corporate training by offering Continuing Education Units (CEUs) that qualify under ANSI/IACET Standard.
"The Authorized Provider status for IACET validates our INC College offerings, which not only provide CEUs for our staff to maintain their industry certifications, but also enhances the expertise of our global teams to provide the highest-quality service to our customers," said Rick Mark, Senior Vice President of Human Resources, INC Research. "We are very proud to achieve this prestigious status in recognition of our efforts to provide our staff with continued learning programs of the highest standard. We want to ensure our employees have the tools and skills they need to do their jobs and, ultimately, provide better satisfaction to our valued clients."
IACET, a non-profit association dedicated to quality continuing education and training programs, is the premier standards-setting organization for continuing education and training. INC Research joins just 650 IACET Authorized Providers around the globe dedicated to quality in continuing education and training. After completing a rigorous application process, including a review by an IACET site visitor, INC Research successfully demonstrated adherence to the appropriate standard addressing the design, development, administration, and evaluation of its training programs. The coveted accreditation period extends for five years and includes all programs offered or created during that time.
INC Research's comprehensive training efforts are offered throughout all career stages, beginning with the hiring process. INC Research provides much of its training via INC College, a proprietary system of hundreds of readily accessible online and offline courses and workshops that can be accessed worldwide. Many of these training programs carry CEUs, all of which are now accredited by IACET.
Further contributing to INC Research's corporate training efforts, Tammi Masters, RN CCRC, Senior Trainer at INC Research, was the only CRO and U.S. representative invited to participate with industry experts on a global taskforce chartered to develop a set of best practice recommendations for effective training of all parties involved in pharmaceutical development and manufacturing. Based on the initiative pioneered by the International Academy of Clinical Research (IAoCR), Masters helped draft new standardized drug development training practice guidelines called GxP Training Guidelines. The draft guidelines were recently released and are now available on the IAoCR website.
About IACET
The International Association for Continuing Education and Training (IACET) is a non-profit association dedicated to quality continuing education and training programs. IACET is the only standard-setting organization approved by the American National Standards Institute (ANSI) for continuing education and training. The ANSI/IACET 1-2007 Standard is the core of thousands of educational programs worldwide. For more information you can visit www.iacet.org
About INC Research, LLC
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areasand innovative pediatric and women's health trials. The Company's Trusted Process(R) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media +1-513-345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Topic: Press release summary
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
